Abstract
PurposeCo-prescription of paroxetine/fluoxetine (a strong CYP2D6 inhibitor) in metoprolol (a CYP2D6 substrate) users is common, but data on the clinic......
小提示:本篇文献需要登录阅读全文,点击跳转登录